These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9710118)
21. The localization of tissue factor and apolipoprotein(a) in atherosclerotic lesions of the human aorta and their relation to fibrinogen-fibrin transition. Ichikawa K; Nakagawa K; Hirano K; Sueishi K Pathol Res Pract; 1996 Mar; 192(3):224-32. PubMed ID: 8739469 [TBL] [Abstract][Full Text] [Related]
22. An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links. Park R; Ping L; Song J; Seo JY; Choi TY; Choi JR; Gorkun OV; Lord ST Thromb Haemost; 2013 Feb; 109(2):199-206. PubMed ID: 23224113 [TBL] [Abstract][Full Text] [Related]
23. Determination of the topology of factor XIIIa-induced fibrin gamma-chain cross-links by electron microscopy of ligated fragments. Weisel JW; Francis CW; Nagaswami C; Marder VJ J Biol Chem; 1993 Dec; 268(35):26618-24. PubMed ID: 7902838 [TBL] [Abstract][Full Text] [Related]
24. Pharmacologic evaluation of factor XIIIa*-like enzyme activity in equine plasma as a potential therapeutic avenue for the inhibition of fibrinous tissue. Coyne CP; Smith JE; DeBowes RM Am J Vet Res; 1992 May; 53(5):695-705. PubMed ID: 1355954 [TBL] [Abstract][Full Text] [Related]
25. Human inter-α-inhibitor is a substrate for factor XIIIa and tissue transglutaminase. Scavenius C; Sanggaard KW; Nikolajsen CL; Bak S; Valnickova Z; Thøgersen IB; Jensen ON; Højrup P; Enghild JJ Biochim Biophys Acta; 2011 Dec; 1814(12):1624-30. PubMed ID: 21939789 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of factor XIIIa-mediated incorporation of fibronectin into fibrin by pulmonary surfactant. Elssner A; Mazur G; Vogelmeier C Am J Physiol; 1999 Apr; 276(4):L625-30. PubMed ID: 10198360 [TBL] [Abstract][Full Text] [Related]
27. Covalent crosslinking of von Willebrand factor to fibrin. Hada M; Kaminski M; Bockenstedt P; McDonagh J Blood; 1986 Jul; 68(1):95-101. PubMed ID: 2872929 [TBL] [Abstract][Full Text] [Related]
28. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. Greenberg CS; Miraglia CC; Rickles FR; Shuman MA J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124 [TBL] [Abstract][Full Text] [Related]
29. Isolation of a fibrin-binding fragment from blood coagulation factor XIII capable of cross-linking fibrin(ogen). Greenberg CS; Enghild JJ; Mary A; Dobson JV; Achyuthan KE Biochem J; 1988 Dec; 256(3):1013-9. PubMed ID: 3066350 [TBL] [Abstract][Full Text] [Related]
30. Lipoprotein (a), LPA Ile4399Met, and fibrin clot properties. Rowland CM; Pullinger CR; Luke MM; Shiffman D; Green L; Movsesyan I; Devlin JJ; Malloy MJ; Kane JP; Undas A Thromb Res; 2014 May; 133(5):863-7. PubMed ID: 24502962 [TBL] [Abstract][Full Text] [Related]
32. A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA. Fukue H; Anderson K; McPhedran P; Clyne L; McDonagh J Blood; 1992 Jan; 79(1):65-74. PubMed ID: 1370210 [TBL] [Abstract][Full Text] [Related]
33. Fibrinogen A alpha and gamma-chain dimers as potential differential indicators of atherosclerotic and thrombotic vascular disease. Shainoff JR; Valenzuela R; Urbanic DA; DiBello PM; Lucas FV; Graor R Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):499-503. PubMed ID: 1983461 [TBL] [Abstract][Full Text] [Related]
34. Thymosin beta4 is released from human blood platelets and attached by factor XIIIa (transglutaminase) to fibrin and collagen. Huff T; Otto AM; Müller CS; Meier M; Hannappel E FASEB J; 2002 May; 16(7):691-6. PubMed ID: 11978733 [TBL] [Abstract][Full Text] [Related]
35. Human procarboxypeptidase U, or thrombin-activable fibrinolysis inhibitor, is a substrate for transglutaminases. Evidence for transglutaminase-catalyzed cross-linking to fibrin. Valnickova Z; Enghild JJ J Biol Chem; 1998 Oct; 273(42):27220-4. PubMed ID: 9765243 [TBL] [Abstract][Full Text] [Related]
37. The inter-relation of fibrin, lipoprotein(a) and plasminogen in human atherosclerotic lesions. Smith EB; Crosbie L; Cochran S Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):495-8. PubMed ID: 2151935 [TBL] [Abstract][Full Text] [Related]
38. Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen. Matsuka YV; Medved LV; Migliorini MM; Ingham KC Biochemistry; 1996 May; 35(18):5810-6. PubMed ID: 8639541 [TBL] [Abstract][Full Text] [Related]
39. Coagulation factor XIIIa undergoes a conformational change evoked by glutamine substrate. Studies on kinetics of inhibition and binding of XIIIA by a cross-reacting antifibrinogen antibody. Mitkevich OV; Shainoff JR; DiBello PM; Yee VC; Teller DC; Smejkal GB; Bishop PD; Kolotushkina IS; Fickenscher K; Samokhin GP J Biol Chem; 1998 Jun; 273(23):14387-91. PubMed ID: 9603949 [TBL] [Abstract][Full Text] [Related]
40. Delayed intermolecular gamma-chain cross-linking by factor XIIIa in fibrinogen Asahi characterized by a gamma-Met-310 to Thr substitution with an N-glycosylated gamma-Asn-308. Yamazumi K; Shimura K; Maekawa H; Muramatsu S; Terukina S; Matsuda M Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):557-9. PubMed ID: 1983463 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]